AstraZeneca Asks Fed. Circ. To Bar Generic Crestor
AstraZeneca Pharmaceuticals LP sought to convince the Federal Circuit on Monday that it could use its method patents for blockbuster cholesterol drug Crestor to block generic versions of the drug even...To view the full article, register now.
Already a subscriber? Click here to view full article